Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Quezada

Showing results (201-210 of 236) with videos related to

Pageof 24
Sort By:
Nature|March 22, 2019
Neoantigen-directed immune escape in lung cancer evolutionRachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, et al.
Nature|April 8, 2026
Synthetic super-enhancers enable precision viral immunotherapyUte Koeber, Mantas Matjusaitis, Neza Alfazema, et al.
Cell|April 15, 2021
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasionEster Gangoso, Benjamin Southgate, Leanne Bradley, et al.
Nature Cancer|March 1, 2021
CD25-T<sub>reg</sub>-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunityIsabelle Solomon, Maria Amann, Anne Goubier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parametersM Linch, G Goh, C Hiley, et al.
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
Cancer Discovery|April 6, 2024
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung CancerKatey S S Enfield, Emma Colliver, Claudia Lee, et al.
Cancer Research|January 14, 2017
RORγt<sup>+</sup> Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast CancersSheeba Irshad, Fabian Flores-Borja, Katherine Lawler, et al.
Nature Medicine|June 5, 2020
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancerKroopa Joshi, Marc Robert de Massy, Mazlina Ismail, et al.
Pageof 24

Showing results (201-210 of 236) with videos related to

Sort By:
Pageof 24
Nature|March 22, 2019
Neoantigen-directed immune escape in lung cancer evolutionRachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, et al.
Nature|April 8, 2026
Synthetic super-enhancers enable precision viral immunotherapyUte Koeber, Mantas Matjusaitis, Neza Alfazema, et al.
Cell|April 15, 2021
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasionEster Gangoso, Benjamin Southgate, Leanne Bradley, et al.
Nature Cancer|March 1, 2021
CD25-T<sub>reg</sub>-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunityIsabelle Solomon, Maria Amann, Anne Goubier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parametersM Linch, G Goh, C Hiley, et al.
Immunity|April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established TumorsFrederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Cancer Cell|March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 AntibodiesFrederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
Cancer Discovery|April 6, 2024
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung CancerKatey S S Enfield, Emma Colliver, Claudia Lee, et al.
Cancer Research|January 14, 2017
RORγt<sup>+</sup> Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast CancersSheeba Irshad, Fabian Flores-Borja, Katherine Lawler, et al.
Nature Medicine|June 5, 2020
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancerKroopa Joshi, Marc Robert de Massy, Mazlina Ismail, et al.
Pageof 24